MSB 4.69% $1.45 mesoblast limited

Yes that's right, "may" !!!How much better is that to the...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,966 Posts.
    lightbulb Created with Sketch. 1361
    Yes that's right, "may" !!!

    How much better is that to the alternative answer to the question asked? What were the alternatives that the FDA could have given?

    IMO " may" is as good as the FDA would say.
    Never have I seen them say "will" as that would undermine the BLA review process.

    They could have agreed to the AA pathway and demanded a trial based on surrogate endpoint. That would take years to complete.

    Then they could have been really negative and said the indication was not suitable for AA and a trial would be required with long term survival of x years as a primary end point.

    What's team Mesoblast doing?
    Filling in BLAs
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.